Tg(Myh6/tetO-PRKCA*)1Jmk
Transgene Detail
|
Symbol: |
Tg(Myh6/tetO-PRKCA*)1Jmk |
Name: |
transgene insertion 1, Jeffery D Molkentin |
MGI ID: |
MGI:3851565 |
Synonyms: |
dnPrkca, Tg(dnPrkca) |
Transgene: |
Tg(Myh6/tetO-PRKCA*)1Jmk Location: unknown
|
Alliance: |
Tg(Myh6/tetO-PRKCA*)1Jmk page
|
|
|
Transgene Type: |
|
Transgenic (Dominant negative, Inducible, Inserted expressed sequence) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Tg(Myh6/tetO-PRKCA*)1Jmk expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Note |
rabbit, European |
PRKCA (100037720) |
|
|
|
|
Mutation details: The rabbit PRKCA cDNA carrying the dominant negative L368A mutation was fused to the cardiac-specific alpha myosin heavy chain (Myh6) mouse promoter. The promoter is minimally active/attenuated through the ablation of three GATA sites and two thyroid-like response elements. Seven copies of tetracycline-responsive promoter element (tetO) are fused to the promoter.
(J:88510, J:132098)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:132098 Hambleton M, et al., Inducible and myocyte-specific inhibition of PKCalpha enhances cardiac contractility and protects against infarction-induced heart failure. Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3768-71 |
All: |
2 reference(s) |
|